FDA Expands Approval of Two Plaque Psoriasis Therapies to Include Younger Patients
The FDA has expanded the approval for Taclonex Topical Suspension and Enstilar Foam, two plaque psoriasis therapies to include younger patients.
All articles by Diana Ernst, RPh
Duobrii Lotion Now Available for Plaque Psoriasis Treatment
Duobrii (halobetasol propionate and tazarotene; Ortho Dermatologics) has been made available for the topical treatment of plaque psoriasis in adult patients.
Isotretinoin Generic Available Again for Severe Acne
Zenatane, a therapeutic equivalent to Accutane, is approved for marketing only under a special restricted distribution as it can cause severe birth defects.
Abrocitinib Looks Promising in Phase 3 Atopic Dermatitis Trial
Top-line results were announced from a phase 3 study evaluating the safety and efficacy of abrocitinib, an oral Janus kinase 1 (JAK1) inhibitor, for the treatment of moderate to severe atopic dermatitis in patients ≥12 years old.
DRESS Associated With Agranulocytosis in a Patient Treated With Oxacillin
A recent report published in the American Journal of Case Reports describes a rare case of drug reaction with eosinophilia and systemic symptoms (DRESS)-induced agranulocytosis in a patient treated with the beta-lactam antibiotic oxacillin.
Next post in General Dermatology
